The Long Non-coding RNA ERIC is Regulated by E2F and Modulates the Cellular Response to DNA Damage

Overview

Journal Mol Cancer

Publisher Biomed Central

Specialties Molecular Biology
Oncology

Date 2013 Oct 31

PMID 24168400

Citations 42

Authors

Orit Feldstein

Tal Nizri

Tirza Doniger

Jasmine Jacob

Gideon Rechavi

Doron Ginsberg

Affiliations

Soon will be listed here.

Abstract

Background: The human genome encodes thousands of unique long non-coding RNAs (lncRNAs), and these transcripts are emerging as critical regulators of gene expression and cell fate. However, the transcriptional regulation of their expression is not fully understood. The pivotal transcription factor E2F1 which can induce both proliferation and cell death, is a critical downstream target of the tumor suppressor, RB. The retinoblastoma pathway is often inactivated in human tumors resulting in deregulated E2F activity.

Results: Here, we report that lncRNA XLOC 006942, which we named ERIC, is regulated by E2F1 and, most probably, also E2F3. We show that expression levels of ERIC were elevated upon activation of exogenous E2F1, E2F3 or endogenous E2Fs. Moreover, knockdown of either E2F1 or E2F3 reduced ERIC levels and endogenous E2F1 binds ERIC's promoter. Expression of ERIC was cell cycle regulated and peaked in G1 in an E2F1-dependent manner. Inhibition of ERIC expression increased E2F1-mediated apoptosis, suggesting that E2F1 and ERIC constitute a negative feedback loop that modulates E2F1 activity. Furthermore, ERIC levels were increased following DNA damage by the chemotherapeutic drug Etoposide, and inhibition of ERIC expression enhanced Etoposide -induced apoptosis.

Conclusions: Our data identify ERIC as a novel lncRNA that is transcriptionally regulated by E2Fs, and restricts apoptosis induced by E2F1, as well as by DNA damage.

Citing Articles

A 5-lncRNA signature predicts clinical prognosis and demonstrates a different mRNA expression in adult soft tissue sarcoma.

Yao Y, Wang X, Zhao Z, Li Z Transl Cancer Res. 2025; 14(1):179-196.

PMID: 39974396 PMC: 11833409. DOI: 10.21037/tcr-24-203.

Long noncoding RNA bridges the DREAM complex and E2f1 to regulate endoreplication in .

Li D, Jin T, Liu J, Lu C, Yang X, Zhang H Sci Adv. 2024; 10(45):eadr4936.

PMID: 39514671 PMC: 11546848. DOI: 10.1126/sciadv.adr4936.

Integrative CRISPR Activation and Small Molecule Inhibitor Screening for lncRNA Mediating BRAF Inhibitor Resistance in Melanoma.

Shamloo S, Kloetgen A, Petroulia S, Hockemeyer K, Sievers S, Tsirigos A Biomedicines. 2023; 11(7.

PMID: 37509693 PMC: 10377043. DOI: 10.3390/biomedicines11072054.

Mechanistic Contributions of lncRNAs to Cellular Signaling Pathways Crucial to the Lifecycle of Human Papillomaviruses.

Arman W, Munger K Viruses. 2022; 14(11).

PMID: 36366537 PMC: 9697900. DOI: 10.3390/v14112439.

Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy.

Wu Y, Su Y, Kuo C Biomedicines. 2022; 10(5).

PMID: 35625948 PMC: 9138696. DOI: 10.3390/biomedicines10051212.

References

Nagano T, Mitchell J, Sanz L, Pauler F, Ferguson-Smith A, Feil R . The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science. 2008; 322(5908):1717-20. DOI: 10.1126/science.1163802. View

Wapinski O, Chang H . Long noncoding RNAs and human disease. Trends Cell Biol. 2011; 21(6):354-61. DOI: 10.1016/j.tcb.2011.04.001. View

Hallstrom T, Nevins J . Balancing the decision of cell proliferation and cell fate. Cell Cycle. 2009; 8(4):532-5. PMC: 3018328. DOI: 10.4161/cc.8.4.7609. View

Amaral P, Mattick J . Noncoding RNA in development. Mamm Genome. 2008; 19(7-8):454-92. DOI: 10.1007/s00335-008-9136-7. View

Wang K, Yang Y, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y . A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011; 472(7341):120-4. PMC: 3670758. DOI: 10.1038/nature09819. View

Dimova D, Stevaux O, Frolov M, Dyson N . Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway. Genes Dev. 2003; 17(18):2308-20. PMC: 196467. DOI: 10.1101/gad.1116703. View

Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M . Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2010; 30(16):1956-62. PMC: 3230933. DOI: 10.1038/onc.2010.568. View

Dong Y, Yang H, McMasters K . E2F-1 overexpression sensitizes colorectal cancer cells to camptothecin. Cancer Gene Ther. 2003; 10(3):168-78. DOI: 10.1038/sj.cgt.7700565. View

Wan G, Mathur R, Hu X, Liu Y, Zhang X, Peng G . Long non-coding RNA ANRIL (CDKN2B-AS) is induced by the ATM-E2F1 signaling pathway. Cell Signal. 2013; 25(5):1086-95. PMC: 3675781. DOI: 10.1016/j.cellsig.2013.02.006. View

10.

Elliott M, Farmer M, Atienza Jr C, Stilwell A, Dong Y, Yang H . E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells. Tumour Biol. 2002; 23(2):76-86. DOI: 10.1159/000059708. View

11.

Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z . LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013; 41(9):4976-87. PMC: 3643595. DOI: 10.1093/nar/gkt182. View

12.

Dinger M, Amaral P, Mercer T, Pang K, Bruce S, Gardiner B . Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation. Genome Res. 2008; 18(9):1433-45. PMC: 2527704. DOI: 10.1101/gr.078378.108. View

13.

Wang K, Chang H . Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011; 43(6):904-14. PMC: 3199020. DOI: 10.1016/j.molcel.2011.08.018. View

14.

Cabili M, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A . Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011; 25(18):1915-27. PMC: 3185964. DOI: 10.1101/gad.17446611. View

15.

Khalil A, Guttman M, Huarte M, Garber M, Raj A, Rivea Morales D . Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009; 106(28):11667-72. PMC: 2704857. DOI: 10.1073/pnas.0904715106. View

16.

Ofir M, Hacohen D, Ginsberg D . MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E. Mol Cancer Res. 2011; 9(4):440-7. DOI: 10.1158/1541-7786.MCR-10-0344. View

17.

Sherr C, McCormick F . The RB and p53 pathways in cancer. Cancer Cell. 2002; 2(2):103-12. DOI: 10.1016/s1535-6108(02)00102-2. View

18.

Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

19.

Huarte M, Guttman M, Feldser D, Garber M, Koziol M, Kenzelmann-Broz D . A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell. 2010; 142(3):409-19. PMC: 2956184. DOI: 10.1016/j.cell.2010.06.040. View

20.

Berkovich E, Ginsberg D . ATM is a target for positive regulation by E2F-1. Oncogene. 2003; 22(2):161-7. DOI: 10.1038/sj.onc.1206144. View